ArticleBlood2007

Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.

Robert Zeiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.